top
Search terms
Results 1 - 2 of 2 - ordered by :
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme
Ejhf

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of ...

European Journal of Heart Failure, Chang, Su Min, Granger, Christopher B., Johansson, Peter A., Kosolcharoen, Peter, McMurray, John J.V., Michelson, Eric L., Murray, David R., Olofsson, Bertil, ...

Date : 01/07/2010 Item size : 163589 bytes
Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme
Ejhf

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of ...

European Journal of Heart Failure, Chang, Su Min, Granger, Christopher B., Johansson, Peter A., Kosolcharoen, Peter, McMurray, John J.V., Michelson, Eric L., Murray, David R., Olofsson, Bertil, ...

Date : 01/07/2010 Item size : 164755 bytes